Status:
COMPLETED
Intramuscular Aripiprazole in Acutely Agitated Patients Diagnosed With Dementia
Lead Sponsor:
Otsuka Pharmaceutical Development & Commercialization, Inc.
Collaborating Sponsors:
Otsuka America Pharmaceutical
Conditions:
Dementia
Alzheimer's Disease
Eligibility:
All Genders
55-95 years
Phase:
PHASE3
Brief Summary
The purpose of this trial is to test the safety \& tolerability of intramuscular aripiprazole in acutely agitated patients diagnosed with Dementia.
Eligibility Criteria
Inclusion
- Acute agitation in Patients with a DSM-IV diagnosis of Alzheimer's, vascular or mixed Dementia.
Exclusion
- Current DSM-IV Axis 1 diagnosis other than Alzheimer's, vascular or mixed Dementia.
Key Trial Info
Start Date :
December 1 2003
Trial Type :
INTERVENTIONAL
End Date :
March 1 2005
Estimated Enrollment :
125 Patients enrolled
Trial Details
Trial ID
NCT00095719
Start Date
December 1 2003
End Date
March 1 2005
Last Update
November 11 2013
Active Locations (14)
Enter a location and click search to find clinical trials sorted by distance.
1
Local Institution
Santa Ana, California, United States
2
Local Institution
Hamden, Connecticut, United States
3
Local Institution
Hialeah, Florida, United States
4
Local Institution
Miami, Florida, United States